Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care

Papaluca, Timothy; McDonald, Lawson; Craigie, A. L.; Gibson, Annabelle; Desmond, Paul; Wong, Darren; Winter, Rebecca; Scott, Nick; Howell, Jessica; Doyle, Joseph S; Pedrana, Alisa; Lloyd, Andrew R.; Stoové, Mark; Hellard, Margaret; Iser, David; Thompson, Alexander

doi:10.1016/j.jhep.2019.01.012

Cited by 87 publications

(73 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Telehealth offers unique opportunities to patients and providers. As the field of medicine progresses, disparities in health care and access remain through all (15) -There is no difference in SVR in patients who underwent telemedicine consultation or standard clinic visits. -Various studies show that rates of initiation of therapy for HCV are higher in the telemedicine group compared to hepatologist-treated patients with HCV.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Telemedicine: An Evolving Field in Hepatology

2019

View full text Add to dashboard Cite

Healthcare delivery has been dramatically changing in recent times with advances in technology. One area of expansion has been the use of telemedicine due to progression in communication technologies. Telemedicine offers the opportunity to overcome barriers of access, improve patient satisfaction, improve healthcare outcomes and streamline communication between patients and providers. The primary modalities of telemedicine can be grouped into categories of ‘remote monitoring,’ ‘store and forward’ and ‘interactive telemedicine.’ These modalities of telemedicine have been practiced and explored within the scope of hepatology such as in liver transplantation, hepatocellular carcinoma and management of chronic hepatitis C (CHC). There are numerous telemedicine‐based CHC management studies and programs that have developed in New Mexico, the Department of Veterans Affairs, as well as globally in Australia and Canada. In Northern California, the University of New Mexico telemedicine‐based model of ‘ECHO’ has been extended to develop community‐based champions to screen‐link‐treat CHC patients with the goal to eliminate hepatitis C. Despite the advantages to telemedicine, there are still many barriers to seamless integration due to reimbursement and up‐front cost. Nevertheless, it remains an essential part in providing world‐class care to liver patients across geographic and economic barriers.

show abstract

Section: Discussionmentioning

confidence: 99%

“… ‐Arora et al ‐Nazareth et al ‐Rossaro et al ‐Beste et al ‐Cooper et al ‐Sterling et al ‐Talal et al ‐Papaluca et al …”

Section: Telemedicine Expanding Into Other Areas Of Hepatologymentioning

confidence: 99%

Telemedicine: An Evolving Field in Hepatology

2019

View full text Add to dashboard Cite

show abstract

“…Another challenge is ensuring prisoners uninterrupted treatment upon release. One study offered prisoners who began DAA therapy whilst in prison but who were released early with their remaining medication to complete treatment in the community . This same study also offered short sentence duration prisoners ineligible for treatment referrals to healthcare services for treatment in the community once released.…”

Section: Wherementioning

confidence: 99%

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Use of POC testing was also associated with shorter time between the steps of patient admission, testing, clinical assessment, and treatment initiation. Finally, barriers to treatment initiation can be improved by employing nurse-led models of HCV care to reduce the need for specialist physicians [32] , [33] . One nurse-led treatment model involving 14 prisons in Australia resulted in a 96% SVR12 rate, while requiring specialist consultation in only 18% of cases [32] .…”

Section: Discussionmentioning

confidence: 99%

“…Finally, barriers to treatment initiation can be improved by employing nurse-led models of HCV care to reduce the need for specialist physicians [32] , [33] . One nurse-led treatment model involving 14 prisons in Australia resulted in a 96% SVR12 rate, while requiring specialist consultation in only 18% of cases [32] . Additionally, use of telemedicine clinics [30] can reduce the need to transport patients between facilities for care.…”

Section: Discussionmentioning

confidence: 99%

The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017

et al. 2020

View full text Add to dashboard Cite

Background High patient turnover presents challenges and opportunity to provide hepatitis C virus (HCV) care in US jails (remand facilities). This study describes the HCV care cascade in the New York City (NYC) jail system during the direct-acting antiviral (DAA) treatment era. Methods Patients admitted to the NYC jail system from January 2014 through December 2017 were included in this retrospective cohort analysis. We describe rates of screening, diagnosis, linkage to jail-based care, and treatment among the overall cohort, and among subgroups with long jail stays (≥120 days) or frequent stays (≥10 admissions). The study protocol was approved by a third-party institutional review board (BRANY, Lake Success, NY). Findings Among the 121,371 patients in our analysis, HCV screening was performed in 40,219 (33%), 4665 (12%) of whom were viremic, 1813 (39%) seen by an HCV clinician in jail, and 248 (5% of viremic patients) started on treatment in jail. Having a long stay (adjusted risk ratio [aRR] 8·11, 95% confidence interval [CI] 6·98, 9·42) or frequent stays (aRR 1·51, 95% CI 1·04, 2·18) were significantly associated with being seen by an HCV clinician. Patients with long stays had a higher rate of treatment (14% of viremic patients). Sustained virologic response at 12 weeks was achieved in 147/164 (90%) of patients with available virologic data. Interpretation Jail health systems can reach large numbers of HCV-infected individuals. The high burden of HCV argues for universal screening in jail settings. Length of stay was strongly associated with being seen by an HCV clinician in jail. Treatment is feasible among those with longer lengths of stay. Funding None.

show abstract

Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care

Cited by 87 publications

References 18 publications

Telemedicine: An Evolving Field in Hepatology

Telemedicine: An Evolving Field in Hepatology

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017

Contact Info

Product

Resources

About